The overall growth in nonerosive reflux disease treatment market witnessed a minor fall in 2020 due to the spread of Covid-19 pandemic. In 2021, rising [read full press release…]
The overall growth in nonerosive reflux disease treatment market witnessed a minor fall in 2020 due to the spread of Covid-19 pandemic. In 2021, rising [read full press release…]
Various studies have concluded that patients with nonerosive reflux disease have 20 to 30% less chances of getting relief from acid-blocking drugs hence making it [read full press release…]
